These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2516430)

  • 21. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.
    Schvarcz R; Weiland O; Wejstål R; Norkrans G; Frydén A; Foberg U
    Scand J Infect Dis; 1989; 21(6):617-25. PubMed ID: 2482536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human alpha-interferon therapy for chronic non-A, non-B hepatitis: second report.
    Kakumu S; Arao M; Yoshioka K; Hayashi H; Kusakabe A; Hirofuji H; Kawabe M
    Am J Gastroenterol; 1990 Jun; 85(6):655-9. PubMed ID: 2112882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
    Jacyna MR; Brooks MG; Loke RH; Main J; Murray-Lyon IM; Thomas HC
    BMJ; 1989 Jan; 298(6666):80-2. PubMed ID: 2493302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
    Ohnishi K; Nomura F; Nakano M
    Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin.
    Schvarcz R; Weiland O; Glaumann H
    Scand J Infect Dis; 1988; 20(2):231-2. PubMed ID: 2456609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic non-A, non-B hepatitis with interferon.
    Karino Y; Matsushima T; Saga A; Tsuyuguchi M; Miyazaki T; Toyota J
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():234-8. PubMed ID: 1909272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic non-A non-B hepatitis treated with interferon].
    Bjøro K; Schrumpf E; Elgjo K; Nordgård K
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1346-8. PubMed ID: 2111053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
    Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
    N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interferon alpha-2a treatment of 26 patients with chronic non-A non-B hepatitis. Predictive factors of response].
    Lunel-Fabiani F; Guivarch P; Valla D; Grippon P; Marques MA; Huraux JM; Le Charpentier Y; Levy VG; Bousquet O; Opolon P
    Gastroenterol Clin Biol; 1990; 14(10):705-9. PubMed ID: 2124569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
    Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
    J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with ribavirin+alpha interferon in HCV chronic active hepatitis non-responders to interferon alone: preliminary results.
    Scotto G; Ferrara S; Mangano A; Conte PE; Tantimonaco G
    J Chemother; 1995 Feb; 7(1):58-61. PubMed ID: 7629562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.